Researchers may have found a new biomarker for acute COVID-19

Researchers have shown that patients with acute COVID-19 infection have increased levels of the cytokine IL-26 in their blood. Moreover, high IL-26 levels correlate with an exaggerated inflammatory response that signifies severe cases of the disease. The findings indicate that IL-26 is a potential biomarker for severe COVID-19.

Leave a Comment